Durabol 100 mg is an oil-based injectable containing Nandrolone Phenylpropionate, manufactured by British Dragon and dosed at 100 mg/mL in a 10 mL vial.
Durabol 100 mg contains nandrolone phenylpropionate (NPP), a short-acting ester of the anabolic-androgenic steroid nandrolone. Like nandrolone decanoate, NPP is a 19-nortestosterone derivative, but the phenylpropionate ester is significantly shorter than the decanoate ester, producing a much faster onset and shorter duration of action . This makes NPP a distinct compound from Decabol 250 mg (nandrolone decanoate), despite sharing the same parent hormone.
Nandrolone itself is FDA-approved in the decanoate form for the management of anemia of renal insufficiency, where it has been shown to increase hemoglobin and red cell mass. The phenylpropionate ester is not approved for human use in the United States, but is commonly encountered in non-medical bodybuilding contexts as an alternative to the longer-acting decanoate ester.
The pharmacokinetic difference between NPP and nandrolone decanoate is substantial. While nandrolone decanoate has a biological half-life of approximately 6–12 days, the phenylpropionate ester has an estimated half-life of approximately 4.5 days. This shorter half-life means that NPP clears the system more quickly, which some users consider advantageous for managing side effects and transitioning into post-cycle therapy .
Durabol 100 mg uses MCT oil as its carrier oil, providing the oil base for the nandrolone phenylpropionate formulation. MCT oil is a commonly used carrier for injectable anabolic preparations, selected for its low viscosity and compatibility with esterified compounds.
Nandrolone phenylpropionate is a short-acting anabolic steroid with a low androgenic profile, offering faster onset and clearance than the decanoate ester of the same parent hormone.
Nandrolone phenylpropionate is the phenylpropionate ester of nandrolone (19-nortestosterone). The esterification of the 17-beta hydroxyl group with a phenylpropionate chain increases the lipophilicity of the molecule, slowing its release from the intramuscular injection depot. However, the phenylpropionate ester is significantly shorter than the decanoate ester, resulting in a faster release profile and shorter duration of action .
Like all nandrolone esters, NPP is a 19-nor compound, meaning it lacks the carbon-19 methyl group present in testosterone. This structural difference reduces its conversion to dihydrotestosterone (DHT) by the 5-alpha reductase enzyme, which contributes to its lower androgenic activity on scalp and prostate compared to testosterone. The compound also has some progestogenic activity, which can contribute to its side effect profile .
The shorter half-life of NPP means that blood levels rise and fall more quickly than with nandrolone decanoate. This has practical implications for injection frequency and for the timing of post-cycle therapy. Community harm-reduction guides note that NPP "kicks in faster and clears faster" than deca, which some users prefer for shorter cycles or for avoiding the long detection window associated with the decanoate ester .
The phenylpropionate ester produces a much faster release profile than the decanoate ester. While nandrolone decanoate requires 6–8 weeks to reach steady state, NPP reaches stable blood levels within 1–2 weeks . This makes NPP suitable for shorter cycles and allows for more rapid clearance before post-cycle therapy .
British Dragon offers both short-acting and long-acting nandrolone preparations. Decabol 250 contains nandrolone decanoate, a long-acting ester with a half-life of approximately 6–12 days. Durabol 100's distinguishing characteristic is its shorter phenylpropionate ester, which provides faster onset and faster clearance. Other injectable options from British Dragon include Boldabol (boldenone undecylenate) and Testabol Depot (testosterone cypionate).
Published laboratory reports for Durabol 100 mg are shown below with the test date, measured result and percentage of the product's 100 mg label claim.
View Report
Laboratory results apply to the specific tested sample represented in each published report and should not be interpreted as a measurement of every vial or production batch.
The information below is provided for educational reference only. Nandrolone phenylpropionate is not approved for human use in the United States. Non-medical use falls outside approved indications.
In non-medical bodybuilding contexts, nandrolone phenylpropionate is commonly referenced at 50 to 100 mg every other day or 100 to 150 mg two to three times weekly . Because of the shorter phenylpropionate ester, more frequent injections are required compared to nandrolone decanoate to maintain stable blood levels. Community discussions describe weekly totals ranging from 200 to 400 mg per week, with some users referencing up to 600 mg weekly .
| Use Case | Common Reference Range | Injection Frequency |
|---|---|---|
| Conservative non-medical (reported) | 50–100 mg per injection | Every other day |
| Standard non-medical (reported) | 100–150 mg per injection | 2–3 times weekly |
| Higher-dose non-medical (reported) | 150–200 mg per injection | Every other day |
These non-medical ranges represent community-reported practices and are not derived from controlled clinical trials for performance enhancement. Cycle duration in non-medical contexts is typically referenced at 8–12 weeks .
In non-medical bodybuilding contexts, nandrolone phenylpropionate is commonly stacked with a testosterone base, such as Testabol Propionate or Testabol Depot. A forum guide emphasizes that nandrolone "should always be taken with testosterone to keep your hormones in check" . The rationale is that nandrolone causes profound suppression of endogenous testosterone production, and its progestogenic activity can contribute to sexual dysfunction when testosterone is not present .
NPP is sometimes preferred over nandrolone decanoate for shorter cycles because it clears the system faster, allowing for earlier initiation of post-cycle therapy .
Nandrolone phenylpropionate shares the side effect profile of all nandrolone esters. The most clinically significant include hematocrit elevation, dyslipidemia, and suppression of endogenous testosterone production. Regular monitoring of CBC, lipid panel, and hormone levels is recommended in community harm-reduction contexts .
Prolactin-related side effects, including sexual dysfunction and gynecomastia, are a particular concern with nandrolone due to its progestogenic activity . Finasteride should not be used alongside nandrolone, as blocking 5-alpha reductase keeps nandrolone in its more potent form and may worsen scalp and prostate effects .
Nandrolone phenylpropionate suppresses the hypothalamic-pituitary-testicular axis. Because of the shorter phenylpropionate ester, PCT can begin sooner than with nandrolone decanoate. Community guides reference starting PCT 3–5 days after the final injection for NPP, compared to 3–4 weeks for nandrolone decanoate . Agents such as Clomiphene or Tamoxifen are commonly referenced for this purpose.
Nandrolone phenylpropionate has no approved human use for performance enhancement. Any information about non-medical use is derived from user-reported practices and is not validated by controlled clinical research. This information does not constitute medical advice.
Nandrolone phenylpropionate is a controlled anabolic steroid with significant cardiovascular, hepatic, and endocrine risks. It is not approved for athletic performance enhancement.
All nandrolone esters carry a boxed warning for peliosis hepatis, a condition in which liver and sometimes splenic tissue is replaced with blood-filled cysts. These cysts are sometimes present with minimal hepatic dysfunction but have been associated with liver failure. Liver cell tumors have also been reported; most are benign and androgen-dependent, but fatal malignant tumors have been reported.
The FDA label for nandrolone decanoate explicitly states: "This drug has not been shown to be safe and effective for the enhancement of athletic performance. Because of the potential risk of serious adverse health effects, this drug should not be used for such purpose". This warning applies to all nandrolone esters.
Non-medical use of nandrolone phenylpropionate falls outside approved indications. Product purity does not establish that non-medical use is safe or appropriate for an individual. The FDA explicitly warns against use for athletic performance enhancement.
Blood lipid changes associated with increased atherosclerosis risk are seen with anabolic steroids, including decreased HDL and sometimes increased LDL cholesterol. These changes may be very marked and could have a serious impact on cardiovascular risk.
Nandrolone can increase hematocrit and red blood cell count. Hemoglobin and hematocrit should be checked periodically for polycythemia. Suppression of endogenous testosterone production is near-total at meaningful doses. In men, treatment can lead to disorders of fertility by repression of sperm formation.
Other potential effects include fluid retention, acne, and, in women, virilization signs such as voice deepening, hirsutism, and clitoral enlargement.
Nandrolone is contraindicated in pregnancy, in men with prostate or breast cancer, and in patients with hypersensitivity to the drug or its excipients. Caution is required in patients with cardiac, renal, or hepatic disease, as edema may occur with or without congestive heart failure.
Medically supervised nandrolone therapy typically involves periodic monitoring of hemoglobin and hematocrit, serum lipids, and liver function. In non-medical harm-reduction contexts, a bloodwork cadence of baseline, week 6, mid-cycle, and end-of-cycle is commonly referenced, including CBC, lipid panel, E2, prolactin, and total/free testosterone .
Store at controlled room temperature (20° to 25°C / 68° to 77°F). Protect from excessive heat, moisture, and direct light. Do not freeze. Inspect the vial and solution before use and do not use a product that appears damaged, contaminated, or otherwise abnormal. Keep out of reach of children.
Durabol 100 mg is supplied through the official British Dragon distribution chain and shipped in original manufacturer packaging with discreet, privacy-focused handling.
The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details. Products are supplied through the official British Dragon distribution chain.
To verify your Durabol 100 mg product, use the security code on the vial label and cross-check it on the British Dragon official site. Official British Dragon presentation and original packaging help reinforce product legitimacy and buyer confidence.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Proper storage conditions help preserve formulation stability and overall product integrity throughout shelf life.
Store at controlled room temperature (20° to 25°C / 68° to 77°F). Protect from excessive heat, moisture, and direct light. Maintaining stable conditions helps preserve the integrity of the oil-based formulation.
Keep the vial in its original packaging until use. Do not freeze. Before administration, inspect the solution and avoid use if it appears cloudy, discolored, contains particulate matter, or if the vial or seal is compromised.
Keep out of reach of children. Follow proper handling and sterile injection practices when administering the product.
Answers to common questions about Durabol 100 mg, nandrolone phenylpropionate, release characteristics, product strength, and related topics.
Durabol 100 mg contains nandrolone phenylpropionate, a short-acting anabolic steroid. Nandrolone itself is FDA-approved in the decanoate form for anemia of renal insufficiency. The phenylpropionate ester is not approved for human use in the United States. In non-medical bodybuilding contexts, NPP is commonly referenced for joint comfort and lean mass gains, though such use falls outside approved indications .
Due to the shorter phenylpropionate ester, nandrolone phenylpropionate requires more frequent injections than nandrolone decanoate. Community protocols typically reference 50–150 mg every other day or 2–3 times weekly . The estimated half-life of the phenylpropionate ester is approximately 4.5 days .
Yes, nandrolone phenylpropionate suppresses endogenous testosterone production. Because of the shorter ester, PCT can begin sooner than with nandrolone decanoate — typically 3–5 days after the final injection . Agents such as Clomiphene or Tamoxifen are commonly referenced for this purpose.
Nandrolone binds to androgen receptors in muscle tissue, stimulating protein synthesis and nitrogen retention. Its 19-nor structure reduces conversion to dihydrotestosterone (DHT), contributing to its lower androgenic activity on scalp and prostate compared to testosterone. The phenylpropionate ester slows release from the injection site, producing an estimated half-life of approximately 4.5 days .
Because of the shorter phenylpropionate ester, NPP reaches stable blood levels more quickly than nandrolone decanoate. Users typically report initial effects on joint comfort and appetite within 1–2 weeks, with changes in body composition beginning around week 3–4 . Cycle duration in non-medical contexts is typically referenced at 8–12 weeks .
There is no universally best nandrolone ester. The choice between NPP and nandrolone decanoate depends on the desired release profile. NPP provides faster onset and faster clearance, making it suitable for shorter cycles and earlier PCT initiation. Nandrolone decanoate provides a slower, more sustained release with less frequent injections. Both share the same parent hormone and side effect profile.
Durabol 100 contains nandrolone phenylpropionate, while Decabol 250 contains nandrolone decanoate. The key difference is the ester: phenylpropionate is a short ester with an estimated half-life of approximately 4.5 days, while decanoate is a long ester with a half-life of approximately 6–12 days. This affects injection frequency, onset of effects, and PCT timing.
Durabol 100 contains nandrolone phenylpropionate, while Testabol Propionate contains testosterone propionate. Both are short-acting esters, but nandrolone is a 19-nortestosterone derivative with lower androgenic activity, while testosterone is the primary male sex hormone. Nandrolone is more commonly referenced for joint comfort, while testosterone is a foundational compound for mass and strength .
Durabol 100 mg is labeled at 100 mg of nandrolone phenylpropionate per mL. In non-medical contexts, per-injection doses of 50–150 mg are commonly referenced, meaning a single 100 mg injection falls within commonly referenced ranges . Weekly totals typically range from 200–400 mg .
Durabol 100 mg is labeled at 100 mg of nandrolone phenylpropionate per mL. It is supplied as an oil-based injectable in a 10 mL vial, giving 1,000 mg of total labeled content per vial, manufactured by British Dragon.
Yes. A published laboratory report dated March 20, 2026 measured Durabol 100 mg at 102.02 mg, equivalent to 102.02% of its 100 mg label claim. The complete report can be viewed in the Lab Reports tab. Laboratory results apply to the tested sample represented by the individual report and should not be interpreted as a measurement of every vial.